📰 Iontech News
Page 15 - Iontech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iontech. Real-time updates on events, politics, business and more.
September 23, 2022
The COVID-19 vaccine unlocked the potential of mRNA technology and new ways of approaching problems, a senior vice president told Insider.
September 22, 2022
Estimated number of people infected by single patient stands at 0.98 as of September 7, marking first time rate has fallen below one since August 9.
September 21, 2022
COVID-19: The health authority said the bivalent mRNA vaccines are not new vaccines, but like the seasonal flu vaccines, they are updated to take into account the new form of virus circulating during the winter season.
September 21, 2022
PARIS, Sept. 20 (Xinhua) -- The French national health authority (HAS) approved on Tuesday three bivalent mRNA vaccines against the COVID-19 Omicron variants fo
September 21, 2022
Insider says local distributor of German-made vaccine has provided clinical data to health authorities, launching weeks-long approval process.
September 18, 2022
The ministry said the patient was returning from abroad when his symptoms were suspected and diagnosed, BNA added. Brazil approves Pfizer vaccine for children as young as six months Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.
September 18, 2022
Following is a summary of current health news briefs. Brazil approves Pfizer vaccine for children as young as six months Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.
September 16, 2022
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency (EMA) has recommended converting
September 13, 2022
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) said that a 30-microgram booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 Vaccine has been recommended for conditional
September 12, 2022
By Stephen Nakrosis Pfizer Inc. and BioNTech SE said Monday the European Medicines Agencys Committee for Medicinal Products for Human Use, or CHMP, recommended a conditional marketing... | September 12, 2022